Spiral Software

"This year has been a transformative one for us at Spiral. Rebuilding our platform from the ground up was no small feat, but the results have been nothing short of remarkable. Today, five projects are thriving on our new system, paving the way for even greater impact. I want to extend my heartfelt congratulations to the entire Spiral team for their dedication, vision, and hard work. And to our clients – thank you for your trust and shared commitment to this journey. Together, we’re driving innovation and setting the stage for better health outcomes for future generations. Here’s to the incredible milestones we’ve achieved – and the exciting future ahead!" ~ Audrey Shearer, Founder & CEO, Spiral Software. Push to Play 👉 https://lnkd.in/gscimeJJ #transformation #healthtech #globalhealthoutcomes #globalcollaboration

Our Technical Support Team is a group of industry experts who exist to ensure we can respond, troubleshoot, and track requests and product enhancements, globally. Our product is utilised all over the world to enhance global health tech collaboration, so our tech support team operates in exactly the same way – support when you need it! From our corner of the world in Aotearoa New Zealand we remain agile, and geared for growth. Meet our support crew: https://lnkd.in/gYq3N8J6

Meet the Team! Amanda is a passionate advocate for empowering medical trial researchers through efficient data management. Driven by her commitment to creating future-focused solutions, she is dedicated to building platforms that support smarter, data-driven research. "I'm proud of the work I’ve done in my career, highlighting opportunities and seeing those improvements through to completion.” Welcome to the world of Spiral, Amanda! ~ 💥 Get to know Amanda: https://lnkd.in/gYz3ikT3 #Growth #Scale #GlobalHealthOutcomes #SpiralSoftware #Spinnaker #HealthTech

We are working with novel clinical trials which span several years, and we need to operate at the leading edge of technological capabilities. Blazor is that: a global software shift which is only the beginning for emerging health tech efficiencies. “Many database developers lack the ability to ensure the longevity of their code and development language. This shift supports the continuity and lifespan of our product well into the future, providing significant benefits to our clients and their novel trial innovation.” — Cain Harland, Technical Lead, Spiral. By investing in this transformative software shift, we can confidently say that our clients’ clinical trials will have the ability to become more effective, efficient and adaptive. Read more – https://lnkd.in/gbJT4bXj #spiralsoftware #novelclinicaltrials #Microsoft #Blazor #Csharp #healthtech #researchinnovation

"Building world-first outcomes can be as transformative as it is tumultuous at times. Yet, I can boldly say that Spiral is a global leader in novel clinical trial innovation and, more specifically, in randomisation. We’re redefining the parameters of randomisation in all its forms and building a future-ready platform with Blazor’s next-gen development framework. As we continue to push the boundaries of what’s possible, we ask only one thing of our clients: to push the boundaries alongside us!" Learn more about our next generation of trial innovation: https://lnkd.in/gy4tjnk8 ~ Audrey Shearer, CEO & Founder, Spiral Software.

"I love solving problems, and figuring out how things fit together and contribute to the end result.” ~ Vanessa ten Broeke Vanessa is driven by a passion for supporting healthcare workers and researchers dedicated to improving patient outcomes. Her motivation lies in creating solutions that simplify the complexities of clinical trials, ultimately enhancing the lives of those on the front lines. With a background in software testing, Vanessa thrives on problem-solving and understanding how systems work together. This analytical mindset enables her to approach challenges with curiosity and creativity, ensuring that she contributes effectively to the wider team’s objectives of quality and consistency. Welcome to the world of Spiral! 👏 ~ 👉 Get to know Vanessa: https://lnkd.in/gKdwAz3f #Growth #Scale #Capacity #GlobalHealthOutcomes #SpiralSoftware #Spinnaker #HealthTech

The clinical research conference circuit across Australasia requires several months of preparation to ensure our team can meaningfully participate, capture insight, and share these reflections across our respective networks. This circuit presents a critical opportunity for collaboration with researchers leading and advancing infectious disease research. A primary message for us all; ‘Engage Early.’ A great example of this was a trial initially designed to administer a daily tablet to women with perinatal infectious diseases. Many of the women enrolled in the trial were experiencing challenging living conditions in lower socio-economic conditions. After further exploration into the success of administering these drugs, the trial was adjusted to a twice-yearly injection. Read more: https://lnkd.in/gvj2XTwt #EngageEarly #ClinicalResearch #NovelClinicalTrials #REMAP-CAP #SNAP #SpiralSoftware #HumanCenteredDesign #DesignThinking #HealthTech #Spinnaker, Audrey Shearer, CEO & Founder of Spiral Software.

Today, we’re attending the #ANZICS Winter Research Forum in Queenstown —a forum dedicated to the Intensive Care Community of Australasia. This event creates space and connections for investigators to gain early advice from their peers, explore research proposals collectively, and foster a collaborative approach to intensive care research. Our CEO, Audrey Shearer, will lead a presentation session titled ’What Trialists Don’t See’ from a developer's perspective. This presentation will cover how platform trials are an emerging innovative design methodology, why they have the potential to be perpetual, and how small design choices within an application can have significant implications for usability, data accuracy, and trial outcomes. If you want to discuss this presentation more directly with Audrey?—Audrey Shearer, [email protected] #ANZICS #IntensiveCareCommunity #NovelTrials #DesignThinking #HumanCenteredDesign #ThoughtLeadership

From Queensland to Sydney, we're now on our way to support the upcoming ANZCA Strategic Research Workshop. This workshop helps strengthen the collaborative approach to multicentre research in anaesthesia, perioperative and pain medicine. Our sponsorship of this workshop aligns perfectly with our new focus area, complementing our involvement in ICU and infectious disease trials. At Spiral, we believe in making the world a better place by reimagining research tools. This workshop, with its emphasis on innovative design methodologies for clinical trials, reinforces this mission. #CTN2024 #ANZCA #clinicaltrials #spiralsoftware #adaptiveplatformtrials #apts #clinicalresearch

That's a wrap on the Australasian Society for Infectious Diseases Clinical Research Network meeting in Queensland. Held at the stunning location on the 78th floor of SkyPoint on the Gold Coast, the view wasn’t the only thing that impressed me. The event was packed with innovative discussions, presentations and insights that provided me with these key takeaways: -It was a privilege hearing our long-time collaborators Professors Joshua Davis and Steven Tong speak on ‘Designing Your Study,’ a topical subject in line with our work at Spiral. - Quick-fire presentations by early career researchers showcased the strong support for infectious disease research, with valuable feedback to help them advance their trials. - The future of infectious disease research is looking bright, with researchers asking innovative questions and considering global impacts, especially in less advantaged regions like parts of Africa and Asia. A major theme was diversity and early engagement: - Engaging with consumer and indigenous groups during the design phase enhances feedback and community involvement. - Adjustments based on community input, like switching to a 6-month injection from a daily pill, led to higher enrolment and engagement. - Engaging early with statisticians and database providers, like us at Spiral, is crucial to avoid dead ends and ensure a smooth trial design and grant submission process. These insights only touched the surface of the learnings we took away, highlighting how valuable these events are for the medical industry and the advancement of treatments for people across the world. -Audrey Shearer, CEO and Founder, Spiral Software #ASID #globalhealthoutcomes #clinicaltrials #randomisation #bespoketrialdesign #infectiousdiseases #spiralsoftware #healthtech #adaptiveclinicaltrials #clinicalresearch #humancenteredtrialdesign